`
`NOVITC(US)00395564
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2168.001
`Regeneron v. Novartis, IPR2021-00816
`
`Novartis Exhibit 2168.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`
`
`
`Novartis Exhibit 2168.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`1.05 N
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`105
`
`Novartis Exhibit 2168.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.009
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0010
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0011
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0012
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0013
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0014
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0015
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0016
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0017
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0018
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2168.0019
`Regeneron v. Novartis, IPR2021-00816
`
`